Product Development to Promote the Global Market Growth

Global implantable collamer lens market is anticipated to grow at a significant CAGR of 13.4% during the forecast period (2024-2031). The ongoing developments in the field of implantable collamer lens to enhance its characteristics is a key factor driving the growth of the global market. The While, the medical equipment sector focuses on implanting devices for distinct purposes, certain factors, such as regulatory approval, biocompatibility, and device indication are universally relevant. Notwithstanding the variations in the materials and purposes employed by each industry, each is unique to its own medical application. Recent developments in global implantable collamer lens market include:

Browse the full report description of “Implantable Collamer Lens Market Size, Share & Trends Analysis Report by Indication (Myopia, Hyperopia and Astigmatism), and by End-user (Hospitals, Ophthalmic Clinics and Other) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/implantable-collamer-lens-market

• In March 2022, STAAR Surgical announced US FDA approval of EVO Visian Implantable CollamerLenses. The EVO lenses provide visual freedom from contact lenses and glasses. Over one million EVO lenses have already been implanted globally. An estimated 100 million US adults ages 21 to 45 who have myopia are potential candidates for EVO, a biocompatible implantable lens that corrects distance vision.

• In January 2021, Alcon announced the launch of AcrySof IQ vivity. It is the first and only non-diffractive extended depth of focus intraocular lens in the US. The latest addition to Alcon’s intraocular lens (IOL) portfolio expands surgeons’ presbyopia-correcting IOL (PC-IOL) offerings. Vivity X-WAVE technology has delivered an extended range of vision while maintaining a monofocal-like visual disturbance profile.

Market Coverage

• The market number available for – 2023-2031

• Base year- 2023

• Forecast period- 2024-2031

• Segment Covered- 

o By Indication

o By End-user

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- includesCarl Zeiss Meditec, Johnson & Johnson, Bausch +Lomb, Alcon and STAAR Surgical,among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Implantable Collamer Lens Market Report Segment

By Indication

• Myopia
• Hyperopia
• Astigmatism

By End-user

• Hospitals
• Ophthalmic Clinics
• Other (Ambulatory Surgical Centers and Eye Research Institutes)

Global Implantable Collamer Lens Market Report Segment by Region

North America

• United States

• Canada

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/implantable-collamer-lens-market